Our Formulation Philosophy
Most skincare brands start with a marketing concept and work backward to find ingredients that support it. AISPIRE MD was built in reverse starting with published clinical evidence, identifying the highest available active concentrations, and then solving for stable, elegant formulations that actually deliver those actives through the skin barrier.
Every ingredient in AISPIRE MD was selected based on three non-negotiable criteria:
- Published peer-reviewed clinical evidence at the concentration used
- A delivery mechanism that actually penetrates the stratum corneum and reaches target skin layers
- A safety profile appropriate for sensitive skin types, including Fitzpatrick III–VI
The result is a line that performs not because of marketing language, but because the science is real.
Liposomal Delivery Technology
Every AISPIRE MD product utilize pharmaceutical-grade liposomal encapsulation technology. Here is why this matters.
Most topical skincare ingredients cannot adequately penetrate the stratum corneum—the skin’s outermost barrier. Studies show that only 8.1% of standard vitamin C is absorbed through the skin after topical application. The vast majority sits on the surface and accomplishes nothing at the cellular level.
Liposomal delivery encases active ingredients in phospholipid bilayer bubbles that are structurally similar to cell membranes. This “membrane mimicking” structure enables lipid exchange with the skin, dramatically increasing penetration depth, active ingredient retention, and delivery to fibroblasts in the dermal layer—exactly where collagen synthesis occurs.
This is not cosmetic marketing language. Liposomal delivery is a pharmaceutical-grade technology used in drug delivery systems. We applied it to skincare so that our clinical concentrations of PDRN, peptides, and botanicals actually reach the skin layers where they produce results.
Published Evidence
- A 2025 study in the Journal of Liposome Research confirmed that liposomal encapsulation dramatically enhances skin penetration by incorporating natural membrane-mimicking phospholipids, enabling seamless lipid exchange and delivering deeper epidermal and dermal access for meaningful collagen synthesis, antioxidative defense, and photoprotection.
- Research published in PM (NIH) confirmed that liposomal encapsulated ascorbic acid demonstrates increased skin permeation, retention, and enhanced collagen synthesis by
fibroblasts compared to free vitamin C application.
The Ingredient Index
Below is a complete reference for everyhero active in the AISPIRE MD line, organized by function. Each entry includes the mechanism of action and the clinical evidence that informed our formulation decisions.
Regeneration & Repair
| Ingredient | Mechanism of Action | Published Evidence |
|---|---|---|
| Salmon PDRN (2% Wild Pacific Salmon) | Activates adenosine A2A receptors triggering fibroblast proliferation, collagen synthesis, angiogenesis (new blood vessel formation), and suppression of inflammatory pathways. Structural compatibility with human skin due to conserved nucleotide building blocks. | 2022 ScienceDirect review: PDRN promotes angiogenesis, cellular activity, collagen synthesis, and soft tissue regeneration via A2A receptor activation. 2025 Journal of Skin and Stem Cell: PDRN enhances collagen synthesis, improves skin elasticity, reduces wrinkles, and accelerates wound healing (VEGF mRNA increase vs. vehicle group, p <0.001). At 2%: documented 30% increase in fibroblast proliferation, 35% increase in collagen synthesis over 8–12 weeks, 45% improvement in hydration after 4 weeks. |
| Centella Asiatica with Madecassoside | Triterpenoid saponins (madecassoside, asiaticoside) work via TGF-β/Smad-driven collagen anabolism, NF-κB attenuation (inflammation reduction), ceramide synthesis (barrier strengthening), and VEGF-mediated angiogenesis. | 2025 Pharmacia review: Centella’s triterpenoids improve histologic and biophysical skin endpoints through multiple complementary pathways. 2015 Journal of Dermatological Treatment meta-analysis: madecassoside at 0.1% showed statistically significant improvements in skin barrier function, wound healing, and inflammation reduction. |
| Acetyl Hexapeptide-8 | Signal peptide that competitively inhibits the SNARE protein complex responsible for muscle contraction, reducing the repetitive facial movements that cause expression lines. Mimics the mechanism of botulinum toxin at the neuromuscular junction—without injection. | Mechanism is well-established across published peptide literature. Provides measurable reduction in wrinkle depth with consistent topical use, with no downtime, cost, or risk associated with injectable neurotoxins. |
Brightening & Pigmentation
| Ingredient | Mechanism of Action | Published Evidence |
|---|---|---|
| 2MNG (2-Mercaptonicotinoyl Glycine) | Cutting-edge melanogenesis inhibitor that binds to melanin precursors before pigment is deposited in keratinocytes, preventing integration into growing melanin chains. Inhibits both eumelanin and pheomelanin synthesis without compromising melanocyte integrity. | No other skincare product currently combines 2MNG with the other actives in this formula. Represents genuine formulation innovation developed through a three-year collaboration with Korean biotech scientists. Documented to lighten existing pigmentation in as early as 2 weeks. |
| Tranexamic Acid | Inhibits binding of plasminogen to keratinocytes (reducing melanocyte tyrosinase activity), suppresses UV-induced prostaglandin release, and exerts anti-inflammatory and antiangiogenic effects that address the vascular component of melasma. | 2026 Journal of Cosmetic Dermatology (Wiley): randomized and comparative studies demonstrate TXA significantly reduces pigmentation indices and improves quality-of-life scores in melasma and PIH. Multimodal mechanisms—antimelanogenic, anti-inflammatory, antiangiogenic. Comparable or superior efficacy to hydroquinone with fewer irritant reactions (AlJabr et al., 2026, DOI: 10.1111/jocd.70692). |
| Cysteamine | Works via three distinct mechanisms: inhibits dopachrome formation (immediate precursor to eumelanin), increases intracellular glutathione (shifting eumelanin toward pheomelanin), and chelates copper ions required for melanogenesis. | 2024 MDPI meta-analysis (8 RCTs): topical cysteamine demonstrated statistically significant MASI score decrease vs. placebo (p = 0.002). Mean 38–58% decrease in mMASI after 120 days. Dermatologica Sinica comparative trial: 37.9% MASI reduction at 12 weeks (p = 0.009)—comparable to hydroquinone/betamethasone. Safe for all phototypes; continuous use without treatment holidays. |
| Glutathione | Master antioxidant and melanogenesis regulator. Inhibits tyrosinase, shifts melanin from darker eumelanin to lighter pheomelanin, and reduces oxidative stress triggering excess pigmentation. Synergizes with cysteamine through complementary pathway modulation. | Liposomal delivery enables penetration to melanocytes in the basal layer of the epidermis at concentrations not achievable with standard topical formulations. |
| Arbutin | Naturally derived glycosylated form of hydroquinone. Inhibits tyrosinase without the safety concerns of hydroquinone. Well-tolerated, established clinical safety record, and stable brightening activity at the enzyme level. | Established clinical safety record across dermatology literature. Approved for use without treatment holidays in all skin phototypes. |
| White Peony Root (Paeonia lactiflora) | Paeoniflorin and related glycosides inhibit melanin synthesis through pathways distinct from other actives in the formula. Anti-inflammatory and antioxidant properties particularly beneficial for sensitive and reactive skin types. | Traditional botanical with a growing evidence base in topical brightening applications. Particularly suitable for patients whose hyperpigmentation is compounded by sensitivity to conventional brighteners. |
| Licorice Root (Glycyrrhiza glabra) | Glabridin—one of the most potent naturally derived tyrosinase inhibitors known—inhibits UVB-induced pigmentation. Demonstrated antioxidant and anti-inflammatory activity. Particularly effective at reducing redness and post-inflammatory pigmentation following acne, laser, or other procedures. | Well-characterized mechanism across cosmeceutical literature. Clinical data supports reduction in UVB-induced pigmentation and post-procedure PIH. |
Anti-Aging & Collagen
| Ingredient | Mechanism of Action | Published Evidence |
|---|---|---|
| Retinol (Dual-Form: Pure + Ester) | Pure retinol converts to retinoic acid in the skin, directly stimulating collagen synthesis, accelerating cell turnover, and reducing MMP enzyme activity (which degrades existing collagen). The retinol ester provides slower, sustained release, reducing peak concentration spikes that cause irritation while extending duration of activity. | Prescription-strength retinoids have been shown to reduce wrinkle depth by up to 35% over six months. Dual-form approach documented to reduce retinol-associated irritation while maintaining clinical efficacy. |
| Bakuchiol | Activates the same gene expression pathways as retinol—upregulating types I, III, and IV collagen, improving skin elasticity, reducing hyperpigmentation, and reducing wrinkle surface area—without structural resemblance to retinol and without the irritation. Amplifies retinol’s anti-aging effect through overlapping pathways while buffering against irritation. | 2019 double-blind RCT (British Journal of Dermatology): 0.5% bakuchiol twice daily vs. 0.5% retinol once daily over 12 weeks—equivalent improvements in wrinkle surface area, pigmentation, and photodamage. Retinol group: significantly more scaling and stinging. Bakuchiol group: no adverse effects. 2021 Journal of Integrative Dermatology: statistically significant wrinkle depth reduction at 4, 8, and 12 weeks (p ≤ 0.01), with increasing significance over time. |
| Vitamin C (Professional Grade, Stabilized) | Required cofactor for prolyl and lysyl hydroxylase enzymes that stabilize the collagen triple helix. Neutralizes reactive oxygen species, reduces melanin synthesis by inhibiting tyrosinase, protects against UV-induced DNA damage, and reduces erythema and post-inflammatory changes. | 2020 Scientific Reports (Nature): lipophilic vitamin C derivatives significantly increased epidermal thickness and favored collagen III production in human skin. Research confirms liposomal delivery achieves up to 4-fold higher bioavailability vs. conventional ascorbic acid. (WBCIL Journal of Liposome Research, 2025) |
| Ferulic Acid | Plant-derived antioxidant that stabilizes vitamin C and vitamin E, extending their active potency by up to 8-fold. Independent photoprotective and anti-aging properties: absorbs UV radiation, reduces UV-induced erythema, and reduces thymine dimer formation (DNA mutations driving photoaging and skin cancer risk). | Vitamin C + ferulic acid combination is one of the most clinically established pairings in evidence-based cosmeceutical science. |
| Arbutin | Naturally derived glycosylated form of hydroquinone. Inhibits tyrosinase without the safety concerns of hydroquinone. Well-tolerated, established clinical safety record, and stable brightening activity at the enzyme level. | Established clinical safety record across dermatology literature. Approved for use without treatment holidays in all skin phototypes. |
| Panax Ginseng (Korean Red Ginseng) | Active ginsenosides stimulate fibroblast proliferation and collagen synthesis, inhibit MMP enzymes degrading existing collagen, reduce melanin production, and increase skin elasticity and firmness. Provides antioxidant protection while supporting structural integrity. | Extensively studied in Korean dermatology. Valued for its dual action—brightening the complexion while simultaneously supporting collagen structure. |
Hydration & Barrier
| Ingredient | Mechanism of Action | Published Evidence |
|---|---|---|
| Hyaluronic Acid | Naturally occurring glycosaminoglycan in the extracellular matrix. Holds up to 1,000 times its weight in water, providing immediate hydration, plumping, and improved texture. Acts as a soothing agent that counterbalances potential irritation from active ingredients. | Most effective hydrating agent in skincare science. Improves skin appearance at the surface level while actives work at the cellular level. |
| Niacinamide (Vitamin B3) | Reduces sebum production, minimizes pore appearance, improves skin barrier function by increasing ceramide synthesis, reduces post-inflammatory hyperpigmentation by inhibiting melanosome transfer from melanocytes to keratinocytes, reduces fine lines, and decreases skin yellowing associated with aging. | ne of the most clinically versatile ingredients in dermatology, with evidence across multiple mechanisms and skin concerns. |
| Rice Bran, Chamomile, Green Tea (Antioxidant Botanical Complex) | Green tea polyphenols (EGCG) neutralize free radicals from UV and pollution. Rice bran delivers gamma-oryzanol and ferulic acid for photoprotection. Chamomile contributes bisabolol, a clinically documented anti-inflammatory reducing erythema and sensitization. Together they protect the formula’s actives from oxidative degradation. | Protects the clinical-concentration actives in each formula from oxidative degradation, extending their efficacy at the skin level. |